» Articles » PMID: 19398958

Vesicle-mediated Secretion of Human Eosinophil Granule-derived Major Basic Protein

Overview
Journal Lab Invest
Specialty Pathology
Date 2009 Apr 29
PMID 19398958
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Major basic protein (MBP), the predominant cationic protein of human eosinophil specific granules, is stored within crystalloid cores of these granules. Secretion of MBP contributes to the immunopathogenesis of varied diseases. Prior electron microscopy (EM) of eosinophils in sites of inflammation noted losses of granule cores in the absence of granule exocytosis and suggested that eosinophil granule proteins might be released through piecemeal degranulation (PMD), a secretory process mediated by transport vesicles. Because release of eosinophil granule-derived MBP through PMD has not been studied, we evaluated secretion of this cationic protein by human eosinophils. Intracellular localizations of MBP were studied within nonstimulated and eotaxin-stimulated human eosinophils by both immunofluorescence and a pre-embedding immunonanogold EM method that enables optimal epitope preservation and antigen access to membrane microdomains. In parallel, quantification of transport vesicles was assessed in eosinophils from a patient with hypereosinophilic syndrome (HES). Our data demonstrate vesicular trafficking of MBP within eotaxin-stimulated eosinophils. Vesicular compartments, previously implicated in transport from granules to the plasma membrane, including large vesiculotubular carriers termed eosinophil sombrero vesicles (EoSVs), were found to contain MBP. These secretory compartments were significantly increased in numbers within HES eosinophils. Moreover, in addition to granule-stored MBP, even unstimulated eosinophils contained appreciable amounts of MBP within secretory vesicles, as evidenced by immunonanogold EM and immunofluorescent colocalizations of MBP and CD63. These data suggest that eosinophil MBP, with its multiple extracellular activities, can be mobilized from granules by PMD into secretory vesicles and both granule- and secretory vesicle-stored pools of MBP are available for agonist-elicited secretion of MBP from human eosinophils. The recognition of PMD as a secretory process to release MBP is important to understand the pathological basis of allergic and other eosinophil-associated inflammatory diseases.

Citing Articles

Eosinophil extracellular vesicles and DNA traps in allergic inflammation.

Weihrauch T, Melo R, Gray N, Voehringer D, Weller P, Raap U Front Allergy. 2024; 5:1448007.

PMID: 39148911 PMC: 11324581. DOI: 10.3389/falgy.2024.1448007.


Extracellular sombrero vesicles are hallmarks of eosinophilic cytolytic degranulation in tissue sites of human diseases.

Neves V, Palazzi C, Malta K, Bonjour K, Kneip F, Dias F J Leukoc Biol. 2024; 116(2):398-408.

PMID: 38527801 PMC: 11271979. DOI: 10.1093/jleuko/qiae079.


In Vivo ETosis of Human Eosinophils: The Ultrastructural Signature Captured by TEM in Eosinophilic Diseases.

Neves V, Palazzi C, Bonjour K, Ueki S, Weller P, Melo R Front Immunol. 2022; 13:938691.

PMID: 35874692 PMC: 9301467. DOI: 10.3389/fimmu.2022.938691.


Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.

Costa V, Sugimoto M, Hubner J, Bonilha C, Queiroz-Junior C, Goncalves-Pereira M Elife. 2022; 11.

PMID: 35293862 PMC: 8959599. DOI: 10.7554/eLife.73853.


Structural and Signaling Events Driving -Induced Human Eosinophil Extracellular Trap Release.

Barroso M, Gropillo I, Detoni M, Thompson-Souza G, Muniz V, Vasconcelos C Front Microbiol. 2021; 12:633696.

PMID: 33679663 PMC: 7930393. DOI: 10.3389/fmicb.2021.633696.


References
1.
Melo R, Spencer L, Perez S, Ghiran I, Dvorak A, Weller P . Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. Traffic. 2005; 6(11):1047-57. PMC: 2715427. DOI: 10.1111/j.1600-0854.2005.00344.x. View

2.
Shahana S, Bjornsson E, Ludviksdottir D, Janson C, Nettelbladt O, Venge P . Ultrastructure of bronchial biopsies from patients with allergic and non-allergic asthma. Respir Med. 2005; 99(4):429-43. DOI: 10.1016/j.rmed.2004.08.013. View

3.
Erjefalt J, Greiff L, Andersson M, Adelroth E, Jeffery P, Persson C . Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease. Thorax. 2001; 56(5):341-4. PMC: 1746051. DOI: 10.1136/thorax.56.5.341. View

4.
Rothenberg M, Hogan S . The eosinophil. Annu Rev Immunol. 2006; 24:147-74. DOI: 10.1146/annurev.immunol.24.021605.090720. View

5.
Dvorak A, Weller P, Letourneau L, Ackerman S . Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab Invest. 1990; 62(5):590-607. View